Ipratropium bromide for acute asthma in children: a retrospective trial.

CONCLUSIONS: The admission rate did not decline with IB use. Several confounding factors could have influenced and limited our results. A prospective study is needed to investigate the effectiveness of IB in Japan.
PMID: 28824036 [PubMed - in process]

Source: Arerugi - August 22, 2017 Category: Allergy & Immunology Authors: Nomura O, Morikawa Y, Hagiwara Y, Ihara T, Inoue N, Sakakibara H, Akasawa A Tags: Arerugi Source Type: research